Providence Regional Cancer Partnership

Recent papers from Providence Regional Cancer Partnership

1. Validation of a tissue-based predictive RNA test for immunotherapy benefit in NSCLC: the PREDAPT studynpj Precision Oncology · 2026
2. Case Report: Durable remission in stage IV melanoma following strategic immune checkpoint inhibitor class rotation and rechallengeFrontiers in Oncology · 2026
3. Overcoming immunotherapy resistance in advanced melanoma through radiotherapy: A prospective observational study.Journal of Clinical Oncology · 2026
4. Implanted Vascular Access Port Flush Frequency: Striking the Balance Between Patient Convenience and Clinical Safety.2026
5. Tumor Microenvironment Lactate: Is It a Cancer Progression Marker, Immunosuppressant, and Therapeutic Target?Molecules · 2025
6. Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT studyJournal for ImmunoTherapy of Cancer · 2024
7. Lactate Oxidase Disrupts Lactate-Activated RAS and PI3K Oncogenic SignalingCancers · 2024
8. Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinomaJournal of Cancer Research and Clinical Oncology · 2023
9. Rare presence of Charcot–Leyden crystals in acute myeloid leukemiaEuropean Journal Of Haematology · 2023
10. Identification of the Collagen Types Essential for Mammalian Breast Acinar StructuresGels · 2022
11. Co‐existence of chronic lymphocytic leukemia and chronic myeloid leukemia and underlying pathogenetic mechanismsEuropean Journal Of Haematology · 2022
12. Human Breast Extracellular Matrix Microstructures and Protein Hydrogel 3D Cultures of Mammary Epithelial CellsCancers · 2021
13. Advances in targeted therapy for acute myeloid leukemiaBiomarker Research · 2020
14. A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple MyelomaClinical Cancer Research · 2018
15. Integration of Palliative Care in End-Stage Liver Disease and Liver TransplantationJournal of Palliative Medicine · 2014
16. The KDM2B- Let-7b -EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic TherapyPLoS ONE · 2014